Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | PTPRC | P08575 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | HTR7 | P34969 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30136447 | 1.00 | ALDH1A1 (0.58) | ALDH1A1KDM4ELMNAGAACA12 | |
| Biphenyl SCHEMBL9989359 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAGAACA12 | |
| SCHEMBL30017788 | 0.98 | ALDH1A1 (0.56) | ALDH1A1KDM4ELMNAGAACA12 | |
| SCHEMBL24106783 | 0.95 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNAGAACA12 | |
| Methyl Alcohol SCHEMBL28372647 | 0.95 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNAGAACA12 | |
| Methylamine SCHEMBL28363123 | 0.95 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNAGAACA12 | |
| SCHEMBL1680715 | 0.93 | ALDH1A1 (0.52) | ALDH1A1KDM4ELMNAGAACA12 | |
| SCHEMBL619334 | 0.91 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNAGAACA12 | |
| SCHEMBL29518802 | 0.91 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNAGAACA12 | |
| SCHEMBL28368328 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KDM4ELMNAGAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078146-A1 | EPHA2 TARGETING AGENTS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-03-19 | — | — | US | claimed |
| US-12570632-B2 | Indole derivatives and uses thereof for treating a cancer | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2026-03-10 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| EP-4605408-A2 | EPHA2 TARGETING AGENTS AND USES THEREOF | The Regents of University of California (US) | 2025-08-27 | — | — | EP | claimed |
| CN-118638089-B | Preparation method for synthesizing flavonoid compound based on carbon dioxide | 湖南工程学院 | 2024-11-12 | — | — | CN | claimed |
| EP-4175718-B1 | INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER | UNIV CLAUDE BERNARD LYON (FR) | 2024-10-02 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| CN-118638089-A | Preparation method for synthesizing flavonoid compound based on carbon dioxide | 湖南工程学院 | 2024-09-13 | — | — | CN | claimed |
| US-12069877-B2 | Composition for manufacturing light-emitting device, light-emitting device manufactured by the same, and method of manufacturing the light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-08-20 | — | — | US | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-0918811-A1 | POLY(ARYLAMINES) AND FILMS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1999-06-02 | — | — | EP | claimed |
| US-5830542-A | Reflective guest-host liquid-crystal display | SONY CORPORATION (JP) | 1998-11-03 | — | — | US | claimed |
| US-5808155-A | HYDROXY COMPOUND | RICOH COMPANY, LTD. (JP) | 1998-09-15 | — | — | US | claimed |
| US-5756493-A | ACTIVE AGAINST METHICILLIN RESISTANT BACTERIA | MICROCIDE PHARMACEUTICALS, INC. (US) | 1998-05-26 | — | — | US | claimed |
| US-5728801-A | FILMS USEFUL AS CHARGE TRANSPORT LAYERS IN LIGHT-EMITTING DIODES | THE DOW CHEMICAL COMPANY (US) | 1998-03-17 | — | — | US | claimed |
| EP-0827366-A2 | Heat-resistant organic electroluminescent device | Hewlett-Packard Company (US) | 1998-03-04 | — | — | EP | claimed |
| WO-1998006773-A1 | POLY(ARYLAMINES) AND FILMS THEREOF | THE DOW CHEMICAL COMPANY (US) | 1998-02-19 | — | — | WO | claimed |
| US-5501930-A | Electrophotographic photoreceptor containing enamine derivative | SHARP KABUSHIKI KAISHA (JP) | 1996-03-26 | — | — | US | claimed |
| US-5475155-A | Reacting an alpha-haloketone with a phenolic-hydroxyl containing compound and a strong protonic acid; neutralization; dehydrohalogenation; dealkylation | THE DOW CHEMICAL COMPANY (US) | 1995-12-12 | — | — | US | claimed |
| US-5121029-A | Displays high brightness by applying low voltage | IDEMITSU KOSAN CO., LTD. (JP) | 1992-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078146-A1 | EPHA2 TARGETING AGENTS AND USES THEREOF | EPHA2, EGFR, DNER | ALDH1A1 3697/4885KDM4E 1441/4885LMNA 2281/4885 |
| US-12570632-B2 | Indole derivatives and uses thereof for treating a cancer | CKS2, CSNK2A3, CSNK1A1L | ALDH1A1 1571/4885KDM4E 2594/4885LMNA 3093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.